Research published in obesity journals consistently documents this phenomenon across diverse patient populations
Nat Med 28(10):20832091 Wadden TA, Hollander P, Klein S et al (2013) Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE maintenance randomized study
Dose escalation is individualized based on response and tolerance, allowing clinicians to find the optimal therapeutic level for each patient
Currently available antiobesity treatments are primarily based on unimolecular [6], and dual molecular [7] hormone-based medications, offering mean weight loss of approximately 1521% [8], [9]
Lifestyle Still Matters Medications are support tools, not replacements for movement, nutrition, and sleep hygiene
The following sections delve into the specific roles of uremic toxins, oxidative stress, inflammation, and iron imbalance in triggering eryptosis, providing a comprehensive overview of the pathophysiological mechanisms underlying renal anemia
